Heart Failure News and Research RSS Feed - Heart Failure News and Research

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
Anaesthesia editorial challenges placenta's role in pre-eclampsia

Anaesthesia editorial challenges placenta's role in pre-eclampsia

Pre-eclampsia, the potentially deadly condition that affects pregnant women, may be caused by problems meeting the oxygen demands of the growing fetus, according to an editorial in the November issue of Anaesthesia, the journal of the Association of Anaesthetists of Great Britain and Ireland. [More]
Rose Medical Center experts perform LARIAT procedure for patients with atrial fibrillation

Rose Medical Center experts perform LARIAT procedure for patients with atrial fibrillation

Rose Medical Center is now performing a groundbreaking procedure for patients with atrial fibrillation (AFib) that may reduce their risk for stroke when they cannot take blood thinners due to special circumstances. [More]
PAP therapy reduces 30-day hospital readmission rates in cardiac patients with sleep apnea

PAP therapy reduces 30-day hospital readmission rates in cardiac patients with sleep apnea

A study of hospitalized cardiac patients is the first to show that effective treatment with positive airway pressure therapy reduces 30-day hospital readmission rates and emergency department visits in patients with both heart disease and sleep apnea. [More]
Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

Heart failure is a debilitating, and life-threatening, condition in which the heart cannot pump enough blood around the body. When heart failure continues to progress and worsen over time, the persistent condition is known as chronic heart failure. [More]
SynCardia Systems wins 2014 New Economy Award for Best Medical Device Company

SynCardia Systems wins 2014 New Economy Award for Best Medical Device Company

SynCardia Systems, Inc., which manufactures the world's only FDA (United States), Health Canada and CE (Europe)-approved Total Artificial Heart, has won the 2014 New Economy Award for Best Medical Device Company. [More]
High doses of fish oil supplements do not reduce atrial fibrillation

High doses of fish oil supplements do not reduce atrial fibrillation

High doses of fish oil supplements, rich in omega-3 fatty acids, do not reduce atrial fibrillation, a common type of irregular heartbeat in which the heart can beat as fast as 150 beats a minute. The results of the AFFORD trial led by the Montreal Heart Institute were published in the Journal of the American College of Cardiology on October 7th. [More]
Women prescribed different medication than men to bring down blood pressure

Women prescribed different medication than men to bring down blood pressure

Women who are treated for high blood pressure are not given the same medication as men, nor do they hit the treatment targets as often, reveals a thesis from the University of Gothenburg. [More]
New miniaturized, wireless monitoring system for heart failure patients

New miniaturized, wireless monitoring system for heart failure patients

A new miniaturized, wireless monitoring system, implanted in the pulmonary artery, is helping keep patients with severe heart failure out of the hospital. Houston Methodist Hospital is the first institution in Houston to offer this to heart failure patients. [More]
ASI treats first patient using Peregrine System Infusion Catheter

ASI treats first patient using Peregrine System Infusion Catheter

Ablative Solutions, Inc., a privately held company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, announced today that it has treated the first patient in the Peregrine Study. [More]
C3BS receives authorization to begin CHART-1 European Phase III trial for C-Cure in Switzerland

C3BS receives authorization to begin CHART-1 European Phase III trial for C-Cure in Switzerland

Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces today it has received authorization from Swissmedic, the Swiss agency for the authorisation and supervision of therapeutic products, to begin its Congestive Heart failure Cardiopoietic Regenerative Therapy (CHART-1) European Phase III trial for C-Cure in Switzerland. [More]
Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

Cumberland Pharmaceuticals Inc. today announced that preoperative intravenous ibuprofen improved overall quality of recovery in patients undergoing laparoscopic cholecystectomy surgery. These results will be presented at the American Anesthesiology 2014 Annual Meeting in New Orleans, Louisiana. [More]
Allscripts FollowMyHealth Achieve now available for patient engagement innovation

Allscripts FollowMyHealth Achieve now available for patient engagement innovation

Allscripts has announced the market launch and general availability of Allscripts FollowMyHealth Achieve, a consumer-friendly, patient engagement innovation intended to mobilize and empower patients as active partners in the management of their care. [More]
Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

Neovasc Inc. today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration to initiate the U.S. arm of its TIARA-I Early Feasibility Trial for the Company's Tiara™ transcatheter mitral valve. [More]

U-M implants CoreValve Evolut R System in patients with severe aortic stenosis

The University of Michigan Frankel Cardiovascular Center is one of the first hospitals in the country to implant Medtronic's new investigational device during transcatheter aortic valve replacement (TAVR). [More]
Arizona resident receives donor heart transplant after living with SynCardia Total Artificial Heart

Arizona resident receives donor heart transplant after living with SynCardia Total Artificial Heart

Randy Shepherd, an Arizona resident nicknamed the "tin man," has received a donor heart transplant after 15 months of support from the SynCardia temporary Total Artificial Heart. [More]
U-M researchers propose new ways to fight sepsis

U-M researchers propose new ways to fight sepsis

A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care. [More]

Elkhart General Hospital named Accredited Heart Failure Center

The Healthcare Colloquium, a Battelle company, announces that Elkhart General Hospital has achieved the designation of being named an Accredited Heart Failure Center. [More]
C3BS inks preferred access agreement with Mayo Clinic

C3BS inks preferred access agreement with Mayo Clinic

Cardio3 BioSciences, a leader in the discovery, development and commercialization of regenerative, protective and reconstructive therapies, announces today the signing of a preferred access agreement with Mayo Clinic. [More]

Cardiac Dimensions adds $8.5M to its previously announced financing

Cardiac Dimensions® today announced the addition of $8.5 million to its previously announced financing. [More]
Ferring Pharmaceuticals to introduce new cranberry flavor option of PREPOPIK in 2015

Ferring Pharmaceuticals to introduce new cranberry flavor option of PREPOPIK in 2015

Colonoscopy is an important and widely used screening tool for colorectal cancer, but for many patients the bowel-preparation process is more uncomfortable than the procedure itself. To offer an alternative choice in bowel preparation, Ferring Pharmaceuticals Inc. will introduce a new cranberry flavor option of PREPOPIK in January 2015. [More]